Paula Cannon

Distinguished Professor · Keck School of Medicine, University of Southern California · company speakers →

Paula Cannon, Ph.D., is a Distinguished Professor at the University of Southern California and the immediate past president of ASGCT. Dr. Cannon uses gene editing to engineer immune cells, with the goal of developing treatments for HIV and other chronic diseases. Most recently, her group has shown that B cells can be reprogrammed to express fully custom antibodies, while retaining the ability to respond to immunization with a matched antigen. This could create boostable B cell factories in the body for the long-term secretion of a range of therapeutic molecules, including broadly neutralizing anti-HIV antibodies that are not currently generated by vaccination.

pharma-biotechhealthcare-services

Is this you? Claim this profile →

No public contact links on file.

Speaking history

American Society of Gene & Cell Therapy Annual Meeting

3 May 2027 Philadelphia, United States “Designing What Nature Can't: Cell and Gene Therapy for HIV”

Topics this speaker covers

pharma-biotechhealthcare-services

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →